The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

BRS in bifurcation lesions

Treatment of bioresorbable scaffold failure

EuroIntervention 2015;11:V175-V180. DOI: 10.4244/EIJV11SVA42

1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Eastern Heart Clinic, Prince of Wales Hospital, Randwick, New South Wales, Australia; 3. Ferrarotto Hospital, University of Catania, Catania, Italy

Bioresorbable scaffolds (BRS) are a promising new interventional treatment strategy for coronary artery disease (CAD). They are intended to overcome some of the shortcomings of metal drug-eluting stents (DES), mainly late rei

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
What about the risk of thrombosis with bioresorbable scaffolds?